Searched for
SPECIALTY CLINICS
Aartas CliniShare to add 20,000 sq. ft of co-working spaceAartas CliniShare aims to add 20,000 sq. ft. of healthcare infrastructure across Delhi NCR by the financial year-end. The company is focusi...- These mid-caps have ‘strong buy’ & ‘buy’ recos and upside potential of up to 28%, according to analystsGlobal markets on Wednesday celebrated the outcome of the US mid-term election as well as a sharp drop in oil prices. Oil prices, which at ...
- The business of running a hospital: Balancing profitability, patient trust and scaleA hospital’s financial health depends on more than occupancy and revenue, requiring a careful balance of cost control, cash flow and patien...
- 4 stocks with consistent score improvement and upside potential of up to 31% in 1 year, according to analystsAlthough the indices are in the green on Monday, the market is extremely volatile. The upmove is being attributed to some recovery in oil p...
- Sun Pharma’s specialty portfolio, Organon deal to drive growthSun Pharmaceutical achieved notable revenue growth in the September quarter, driven by strong performance in India and specialty medicines....
- Short-term headwinds, yes; owning the ecosystem is better: 20 healthcare stocks with downside risk of 23% to upside potential of 41%The healthcare sector is under scrutiny. The issue is pricing: What medicines cost and on what hospitals and the rest of the health ecosyst...
- Hospital balance sheet: How AI could cut costs and improve efficiencyAs hospitals grapple with soaring costs in drugs, supplies, and labor, the integration of AI emerges as a vital necessity.
- Paras Healthcare shares to list today: Check GMP ahead of debutThe Rs 1,450-crore IPO comprised a fresh issue of 72.15 lakh shares worth Rs 500 crore and an offer for sale (OFS) of 1.37 crore shares agg...
- VCs go deep on single-specialty healthcare with orthopaedics, pain relief betsThe trend is reflected in several recent funding deals. Bengaluru-based Lumov, which makes orthotic products, is in talks to raise Rs 32 cr...
- GDHS 2026 to focus on implementing AI actionScheduled for 20-21 November 2026, the Global Digital Health Summit will take place in New Delhi, highlighting the role of artificial intel...
- Paras Healthcare IPO Day 2: GMP at 4%; check subscription status and key detailsParas Healthcare has launched its IPO, starting on October 21 and concluding on October 23. By October 22, participation had reached only 1...
- These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsThe last few weeks have made one thing clear. Oil prices, US bond yields, corporate earnings, and the state of the world – all point the sa...
- Barbera Thornhill says her father invented a medical procedure so ‘millions of people’ can hear again; here is a fact check as she joins Katie Zacharia in making tall claimsBarbera Thornhill's recent role as Ambassador-at-Large to Monitor and Combat Trafficking in Persons has led to intense debate. Her appearan...
- Paras Healthcare IPO opens for subscription: Check GMP, price band and key detailsParas Healthcare’s Rs 1,450 crore IPO opened for subscription on October 21 and closes on October 23, with a grey market premium (GMP) of a...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up 32%, according to analystsHistory tells us that there is no way you can time the markets or predict its movement. But one thing can certainly be said: If the macro m...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsThe next few weeks are critical, and one should not be in a hurry to make market-related decisions. Better to be cautious – to wait and wat...
- Paras Healthcare fixes IPO price band at Rs 660-693; issue opens on Oct 21Paras Healthcare has set its IPO price band at Rs 660-693 per share, targeting Rs 1,450 crore. Opening October 21, the issue will fund debt...
- Long-term investing is about looking beyond narratives, including AI: 5 large-caps with an upside potential of up to 24%As we see a recovery in the market, it is good to be cognizant of the fact that more than the narratives on the street, it is the earnings ...
- CCI nod to Tribhovandas Bhimji Zaveri, Cloudnine, and Farmart dealsThe Competition Commission of India has sanctioned three key transactions across various industries. Notably, GRT Jewellers' majority stake...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%A piece of advice for those who still have the stomach to invest in the current volatile market. Don’t take any price action as the gospel ...
Load More
